Lyell Immunopharma, Inc.LYELNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank17
3Y CAGR-9.1%
5Y CAGR-1.5%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-9.1%/yr
Annual compound
5Y CAGR
-1.5%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$203.81M-43.2%
2024$358.82M+45.2%
2023$247.14M-9.1%
2022$271.74M+20.5%
2021$225.43M+2.6%
2020$219.69M+113.8%
2019$102.75M-